Advertisement
Research Article Free access | 10.1172/JCI105688
Department of Medicine, School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania
Department of Physiology, Graduate Division, School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania
‡Trainee in Hematology under Training Grant T1-AM-5228 from the National Institute of Arthritis and Metabolic Disease, National Institutes of Health, Bethesda, Md.
§Recipient of U. S. Public Health Service Research Career Program Award K3-HE-11, 564 from the National Heart Institute.
ǁRecipient of U. S. Public Health Service Research Career Program Award K3-HE-2629 from the National Heart Institute.
Address requests for reprints to Dr. Peter White, Hospital of the University of Pennsylvania, Philadelphia, Pa. 19104.
*Received for publication 8 March 1967 and in revised form 19 July 1967.
Presented in part before the American Society of Hematology, Seattle, Wash., November 1964 (Blood. 1964. 24: 845. Abstr.). Supported in part by Grant AM-07301, from the National Institute of Arthritis and Metabolic Diseases, U. S. Public Health Service, Bethesda, Md., the Life Insurance Medical Research Fund, and Clinical Research Center Grant 3MO1 FR-40, Division of Research Facilities and Resources, National Institutes of Health.
Find articles by White, P. in: JCI | PubMed | Google Scholar
Department of Medicine, School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania
Department of Physiology, Graduate Division, School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania
‡Trainee in Hematology under Training Grant T1-AM-5228 from the National Institute of Arthritis and Metabolic Disease, National Institutes of Health, Bethesda, Md.
§Recipient of U. S. Public Health Service Research Career Program Award K3-HE-11, 564 from the National Heart Institute.
ǁRecipient of U. S. Public Health Service Research Career Program Award K3-HE-2629 from the National Heart Institute.
Address requests for reprints to Dr. Peter White, Hospital of the University of Pennsylvania, Philadelphia, Pa. 19104.
*Received for publication 8 March 1967 and in revised form 19 July 1967.
Presented in part before the American Society of Hematology, Seattle, Wash., November 1964 (Blood. 1964. 24: 845. Abstr.). Supported in part by Grant AM-07301, from the National Institute of Arthritis and Metabolic Diseases, U. S. Public Health Service, Bethesda, Md., the Life Insurance Medical Research Fund, and Clinical Research Center Grant 3MO1 FR-40, Division of Research Facilities and Resources, National Institutes of Health.
Find articles by Coburn, R. in: JCI | PubMed | Google Scholar
Department of Medicine, School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania
Department of Physiology, Graduate Division, School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania
‡Trainee in Hematology under Training Grant T1-AM-5228 from the National Institute of Arthritis and Metabolic Disease, National Institutes of Health, Bethesda, Md.
§Recipient of U. S. Public Health Service Research Career Program Award K3-HE-11, 564 from the National Heart Institute.
ǁRecipient of U. S. Public Health Service Research Career Program Award K3-HE-2629 from the National Heart Institute.
Address requests for reprints to Dr. Peter White, Hospital of the University of Pennsylvania, Philadelphia, Pa. 19104.
*Received for publication 8 March 1967 and in revised form 19 July 1967.
Presented in part before the American Society of Hematology, Seattle, Wash., November 1964 (Blood. 1964. 24: 845. Abstr.). Supported in part by Grant AM-07301, from the National Institute of Arthritis and Metabolic Diseases, U. S. Public Health Service, Bethesda, Md., the Life Insurance Medical Research Fund, and Clinical Research Center Grant 3MO1 FR-40, Division of Research Facilities and Resources, National Institutes of Health.
Find articles by Williams, W. in: JCI | PubMed | Google Scholar
Department of Medicine, School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania
Department of Physiology, Graduate Division, School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania
‡Trainee in Hematology under Training Grant T1-AM-5228 from the National Institute of Arthritis and Metabolic Disease, National Institutes of Health, Bethesda, Md.
§Recipient of U. S. Public Health Service Research Career Program Award K3-HE-11, 564 from the National Heart Institute.
ǁRecipient of U. S. Public Health Service Research Career Program Award K3-HE-2629 from the National Heart Institute.
Address requests for reprints to Dr. Peter White, Hospital of the University of Pennsylvania, Philadelphia, Pa. 19104.
*Received for publication 8 March 1967 and in revised form 19 July 1967.
Presented in part before the American Society of Hematology, Seattle, Wash., November 1964 (Blood. 1964. 24: 845. Abstr.). Supported in part by Grant AM-07301, from the National Institute of Arthritis and Metabolic Diseases, U. S. Public Health Service, Bethesda, Md., the Life Insurance Medical Research Fund, and Clinical Research Center Grant 3MO1 FR-40, Division of Research Facilities and Resources, National Institutes of Health.
Find articles by Goldwein, M. in: JCI | PubMed | Google Scholar
Department of Medicine, School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania
Department of Physiology, Graduate Division, School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania
‡Trainee in Hematology under Training Grant T1-AM-5228 from the National Institute of Arthritis and Metabolic Disease, National Institutes of Health, Bethesda, Md.
§Recipient of U. S. Public Health Service Research Career Program Award K3-HE-11, 564 from the National Heart Institute.
ǁRecipient of U. S. Public Health Service Research Career Program Award K3-HE-2629 from the National Heart Institute.
Address requests for reprints to Dr. Peter White, Hospital of the University of Pennsylvania, Philadelphia, Pa. 19104.
*Received for publication 8 March 1967 and in revised form 19 July 1967.
Presented in part before the American Society of Hematology, Seattle, Wash., November 1964 (Blood. 1964. 24: 845. Abstr.). Supported in part by Grant AM-07301, from the National Institute of Arthritis and Metabolic Diseases, U. S. Public Health Service, Bethesda, Md., the Life Insurance Medical Research Fund, and Clinical Research Center Grant 3MO1 FR-40, Division of Research Facilities and Resources, National Institutes of Health.
Find articles by Rother, M. in: JCI | PubMed | Google Scholar
Department of Medicine, School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania
Department of Physiology, Graduate Division, School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania
‡Trainee in Hematology under Training Grant T1-AM-5228 from the National Institute of Arthritis and Metabolic Disease, National Institutes of Health, Bethesda, Md.
§Recipient of U. S. Public Health Service Research Career Program Award K3-HE-11, 564 from the National Heart Institute.
ǁRecipient of U. S. Public Health Service Research Career Program Award K3-HE-2629 from the National Heart Institute.
Address requests for reprints to Dr. Peter White, Hospital of the University of Pennsylvania, Philadelphia, Pa. 19104.
*Received for publication 8 March 1967 and in revised form 19 July 1967.
Presented in part before the American Society of Hematology, Seattle, Wash., November 1964 (Blood. 1964. 24: 845. Abstr.). Supported in part by Grant AM-07301, from the National Institute of Arthritis and Metabolic Diseases, U. S. Public Health Service, Bethesda, Md., the Life Insurance Medical Research Fund, and Clinical Research Center Grant 3MO1 FR-40, Division of Research Facilities and Resources, National Institutes of Health.
Find articles by Shafer, B. in: JCI | PubMed | Google Scholar
Published December 1, 1967 - More info
The rate of endogenous carbon monoxide production (˙Vco), determined by the closed rebreathing system technique, was elevated above the normal range in four of five patients studied with ineffective erythropoiesis (four patients with primary refractory anemia, one with thalassemia). The mean molar ratio of ˙Vco to ˙Vheme (rate of circulating heme catabolism, determined from 51Cr red cell survival curves) was 3.0 ± 0.6 (SE), indicating that most of the CO originated from sources other than circulating erythrocyte hemoglobin, in contrast to previous findings in patients with hemolytic anemia, where ˙Vco paralleled ˙Vheme closely.
After administration of glycine-2-14C to these patients, endogenous CO was isolated by washout of body CO stores at high pO2 or by reacting peripheral venous blood samples with ferricyanide. The CO was then oxidized to CO2 by palladium chloride and trapped for counting in a liquid scintillation spectrometer. “Early labeled” peaks of 14CO were demonstrated which paralleled “early labeled” peaks of stercobilin and preceded maximal labeling of circulating heme. Production of “early labeled” 14CO in patients with ineffective erythropoiesis was greatly increased, up to 14 times that found in a normal subject.
The increased ˙Vco and “early 14CO” production shown by these patients are presumably related mainly to heme catabolism in the marrow. The possibility exists that hepatic heme and porphyrin compounds may also contribute significantly to ˙Vco, as suggested by the finding of a high ˙Vco in an additional patient with porphyria cutanea tarda.